Another one! Haha.
Added back corporate costs to group EBITDA for first 4 months ~A13.4m. ARISTO was stated to have made A6.2m, which roughly means DSV made A7.2m for period. However, in the Q1 update DSV made ~A6.2m. Basically DSV made a mere ~A1m in October. However on the average turnover in Q1, it may not be better than A1.5 per month on an ongoing basis.
2020, page-44
Add DNA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $35.82M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 450000 | 2.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.1¢ | 45000 | 1 |
View Market Depth
| Last trade - 16.14pm 09/08/2024 (20 minute delay) ? |
| DNA (ASX) Chart |
Day chart unavailable